Axcelead is Japan's first provider of integrated drug discovery services

We are pleased to announce that Axcelead Drug Discovery Partners, Inc. (Yoshinori Ikeura, President; Headquarters: Fujisawa-shi, Kanagawa, Japan; hereinafter referred to as “Axcelead”) and Leiden Experts on Advanced Pharmacokinetics & Pharmacodynamics Consultants BV (Henk-Jan Drenth, Managing Director; Headquarters: Leiden, the Netherlands; hereinafter referred to as “LAP&P”) decided to develop a business partnership for services provided by Axcelead, in the field of pharmacokinetic and pharmacodynamic analyses (hereinafter referred to as “PK/PD analyses”) and modeling and simulation (hereinafter referred to as “M&S”). We great appreciate that total hundreds of visitors dropped by our booth.

Takeda Pharmaceutical Company Limited [TSE: 4502] (Headquarters: Osaka, Japan; "Takeda") and Axcelead Drug Discovery Partners, Inc. (Headquarters: Kanagawa, Japan; former name: "PRE Business preparation Company," "AXCELEAD") announced the start of operations for AXCELEAD occurred on July 1, 2017. AXCELEAD is the receiving company to which Takeda...